CN106937733A - 一种具有保健功能的牛肉汤及其制备方法 - Google Patents
一种具有保健功能的牛肉汤及其制备方法 Download PDFInfo
- Publication number
- CN106937733A CN106937733A CN201710191365.0A CN201710191365A CN106937733A CN 106937733 A CN106937733 A CN 106937733A CN 201710191365 A CN201710191365 A CN 201710191365A CN 106937733 A CN106937733 A CN 106937733A
- Authority
- CN
- China
- Prior art keywords
- bone
- beef
- healthcare function
- steamed
- soup
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015278 beef Nutrition 0.000 title claims abstract description 63
- 235000014347 soups Nutrition 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 44
- 239000003814 drug Substances 0.000 claims abstract description 18
- 235000013305 food Nutrition 0.000 claims abstract description 16
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 15
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 15
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 14
- 235000008397 ginger Nutrition 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 13
- 241000026010 Dendrobium candidum Species 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 241000234314 Zingiber Species 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 239000002893 slag Substances 0.000 claims description 4
- 240000004638 Dendrobium nobile Species 0.000 claims description 2
- 230000036541 health Effects 0.000 abstract description 11
- 235000005911 diet Nutrition 0.000 abstract description 7
- 230000037213 diet Effects 0.000 abstract description 6
- 230000000050 nutritive effect Effects 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 3
- 244000273928 Zingiber officinale Species 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000006870 function Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 208000037093 Menstruation Disturbances Diseases 0.000 description 4
- 206010027339 Menstruation irregular Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000011132 hemopoiesis Effects 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- 235000019158 vitamin B6 Nutrition 0.000 description 3
- 239000011726 vitamin B6 Substances 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 208000006278 hypochromic anemia Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- IQVQXVFMNOFTMU-FLIBITNWSA-N (Z)-ligustilide Chemical compound C1CC=CC2=C1C(=C/CCC)/OC2=O IQVQXVFMNOFTMU-FLIBITNWSA-N 0.000 description 1
- MZLKNWMNBXHXMA-UHFFFAOYSA-N 1-phenylheptylbenzene Chemical compound C=1C=CC=CC=1C(CCCCCC)C1=CC=CC=C1 MZLKNWMNBXHXMA-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- IQVQXVFMNOFTMU-DHZHZOJOSA-N Z-ligustilide Natural products C1CC=CC2=C1C(=C/CCC)\OC2=O IQVQXVFMNOFTMU-DHZHZOJOSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003262 anti-osteoporosis Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000005860 defense response to virus Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000020903 low-carbon-diet Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000031990 negative regulation of inflammatory response Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 1
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000001720 vestibular Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- -1 wherein Chemical compound 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种具有保健功能的牛肉汤及其制备方法，原料包括食材和中药材，所述的食材包括牛骨和牛肉；所述的中药材包括当归，熟地，桂皮，生姜，铁皮石斛；本发明的有益效果是：能够有效的改善身体状况，并且口感好，味道好，在具有药性的同时具有营养价值，能够促进人们坚持的饮食，从而保证了对身体的保健。
Description
技术领域
本发明属于保健食品领域，具体涉及的是一种具有保健功能的牛肉汤及其制备方法。
背景技术
随着社会的发展、人们的生活节奏越来越快，为了节约时间，对食品的需求也越来越多，现在的人们的身体表面健康，实则为亚健康，多多少少的都存在一些问题，而人们也越来越重视自身的身体的健康情况，但是现有的能够改变身体健康情况的多为中药，中药为多种药材混合搭配，从而产生一定的药理作用，但是中药味道特别苦，而且口感不好，仅仅具有药性，不具有营养价值，也有一些人们通过食疗来保健身体，但是现在的食疗多为纯粹的食疗，即通过身体对食物的吸收率，和食物所存在的营养价值来改善身体状况，食疗虽然味道好，口感好，但是缺少药性，治疗效果差，而且周期长。
营养学中最近的争论围绕着低碳饮食和以牛肉取代鸡、鱼肉这两个话题进行。牛肉又一次被尊为增长肌肉饮食计划中最重要的一部分。以下便是将牛肉列入日常饮食的九大裨益：
1.牛肉富含肌氨酸，牛肉中的肌氨酸含量比任何其它食品都高，这使它对增长肌肉、增强力量特别有效。
2.牛肉含维生素B6，蛋白质需求量越大，饮食中所应该增加的维生素B6就越多。牛肉含有足够的维生素B6，可帮你增强免疫力，促进蛋白质的新陈代谢和合成。
3.牛肉含肉毒碱，鸡肉、鱼肉中肉毒碱和肌氨酸的含量很低，牛肉却含量很高。肉毒碱主要用于支持脂肪的新陈代谢，产生支链氨基酸。
4.牛肉含钾和蛋白质，钾是大多数运动员饮食中比较缺少的矿物质。钾的水平低会抑制蛋白质的合成以及生长激素的产生，从而影响肌肉的生长。
5.牛肉是亚油酸的低脂肪来源，牛肉中脂肪含量很低，但却富含结合亚油酸，这些潜在的抗氧化剂可以有效对抗举重等运动中造成的组织损伤。
6.牛肉含锌、镁，锌是另外一种有助于合成蛋白质、促进肌肉生长的抗氧化剂。锌与谷氨酸盐和维生素B6共同作用，能增强免疫系统。镁则支持蛋白质的合成、增强肌肉力量，更重要的是可提高胰岛素合成代谢的效率。
7.牛肉含铁，铁是造血必需的矿物质。与鸡、鱼、火鸡中少得可怜的铁含量形成对比的是，牛肉中富含铁质。
8.牛肉含丙胺酸，丙胺酸的作用是从饮食的蛋白质中产生糖分。
9.牛肉含维生素B12，维生素B12对细胞的产生至关重要，而红细胞的作用是将氧带给肌肉组织。维生素B12能促进支链氨基酸的新陈代谢。
但是现有的牛肉的食用方法仅仅是为了增加自身营养，并不能够对身体的保健作用。
发明内容
为解决上述问题，本发明提供了一种具有保健功能，口感好的，药性高的牛肉汤及其制备方法。
为实现上述目的，本发明采用的技术方案是，一种具有保健功能的牛肉汤，其特征在于：原料包括食材和中药材，所述的食材包括牛骨和牛肉；所述的中药材包括当归，熟地，桂皮，生姜，铁皮石斛。
作为本发明的优选方案，原料配比为牛骨500g-800g，牛肉100g-250g，当归20g-30g，熟地30g-50g，桂皮40g-50g，生姜5g-10g，铁皮石斛10g-20g。
作为本发明的优选方案，牛骨健康牛骨。
作为本发明的优选方案，牛肉为除酸牛肉。
一种具有保健功能的牛肉汤，其制作方法是：
S1.选择优质的牛骨和牛肉，将牛骨和牛肉清洗干净后晾干；
S2.将晾干的牛骨粉碎成碎牛骨，并滤出比较细小的骨渣；
S3.将碎牛骨放在锅内小火煮20分钟后，将当归，熟地，桂皮，生姜，铁皮石斛放入锅内继续小火煮12小时；
S4.将牛肉切碎后放入锅内煮30分钟。
作为本发明的优选方案，步骤S2中对碎牛骨的过滤采用50目筛网。
本发明的有益效果是：能够有效的改善身体状况，并且口感好，味道好，在具有药性的同时具有营养价值，能够促进人们坚持的饮食，从而保证了对身体的保健。
具体实施方式
下面结合具体实施例对本发明做进一步的解释说明，但不限制本发明的保护范围。
实施例一
一种具有保健功能的牛肉汤，其特征在于：原料包括食材和中药材，所述的食材包括牛骨和牛肉；所述的中药材包括当归，熟地，桂皮，生姜，铁皮石斛。
所述的原料配比为牛骨800g，牛肉250g，当归0g，熟地50g，桂皮50g，生姜10g，铁皮石斛20g。
所述的牛骨健康牛骨。
所述的牛肉为除酸牛肉。
一种具有保健功能的牛肉汤，其制作方法是：
S1.选择优质的牛骨和牛肉，将牛骨和牛肉清洗干净后晾干；
S2.将晾干的牛骨粉碎成碎牛骨，并滤出比较细小的骨渣；
S3.将碎牛骨放在锅内小火煮20分钟后，将当归，熟地，桂皮，生姜，铁皮石斛放入锅内继续小火煮12小时；
S4.将牛肉切碎后放入锅内煮30分钟。
所述的步骤S2中对碎牛骨的过滤采用50目筛网。
实施例二
一种具有保健功能的牛肉汤，其特征在于：原料包括食材和中药材，所述的食材包括牛骨和牛肉；所述的中药材包括当归，熟地，桂皮，生姜，铁皮石斛。
2.根据权利要求1所述的一种具有保健功能的牛肉汤，其特征在于：所述的原料配比为牛骨500g，牛肉100g，当归20g，熟地30g，桂皮40g，生姜5g，铁皮石斛10g。
所述的牛骨健康牛骨。
所述的牛肉为除酸牛肉。
一种具有保健功能的牛肉汤，其制作方法是：
S1.选择优质的牛骨和牛肉，将牛骨和牛肉清洗干净后晾干；
S2.将晾干的牛骨粉碎成碎牛骨，并滤出比较细小的骨渣；
S3.将碎牛骨放在锅内小火煮20分钟后，将当归，熟地，桂皮，生姜，铁皮石斛放入锅内继续小火煮12小时；
S4.将牛肉切碎后放入锅内煮30分钟。
所述的步骤S2中对碎牛骨的过滤采用50目筛网。
生姜：味辛、温。发表，散寒，止呕，健胃，解毒。主治风寒感冒、喘咳、呕吐、痰饮等。主要含有挥发油、姜辣素、二苯基庚烷、黄酮类等化学物质。具有止呕、促进消化、改善血液循环、缓解前庭刺激、抗炎、抑菌、抗肿瘤、增强免疫、健胃与抗胃溃疡、利胆与保肝、强心、抗氧化等作用。
铁皮石斛：味甘微寒，归胃、肾经，具有益胃生津、滋阴清热等功效，主治热病津伤、口干烦渴、胃阴不足、食少干呕、病后虚热不退、阴虚火旺、骨蒸劳热、目暗不明、筋骨痿软等症。主要含有多糖、生物碱、多肽、氨基酸、挥发油及其微量元素等化学物质。具有增强免疫、抗氧化、降血糖，抗肿瘤等药理作用。
熟地：性微温，味甘，功用滋阴，补血。用于阴虚血少，腰膝痿弱，劳嗽骨蒸，遗精，崩漏，月经不调，消渴，耳聋，目昏。可用于治疗血虚萎黄，眩晕，心悸失眠，月经不调，崩漏，亦可用于肾阴不足的潮热骨蒸、盗汗、遗精、消渴、眩晕、耳鸣、须发早白。具有调节与增强免疫、抗衰老、降血糖、促凝血和造血、抗氧化、降压等作用。
桂皮：味微甜辛、性温。有祛寒止痛、温脾胃、暖肝肾、主脘腹冷痛、呕吐泄泻、健胃的功效，其镇痛、解痉作用显著。在临床上常用于用于治理肾阳不足的畏寒、肢冷、腰膝冷痛,，治疗寒凝气滞引起的痛经、月经不调、妇女产后血瘀腹痛、肢体疼痛、散瘀消肿。亦可用于肾不纳气的虚喘、气逆；也用于脾胃虚寒的胃脘冷痛，以及腹痛腹泻。主要含有桂皮醛、苯丙烯酸类化合物、桂皮油、丁香醛及挥发油等成分。具有镇痛、解痉、解热、抗肿瘤、抗炎、抗溃疡、抑制细菌酶、抑制寄生虫运动、抗过敏、抗血栓及血小板聚集等作用。
当归：温，味甘，辛。当归，归心、脾经。具有补血活血.调经止痛.润肠通便的功效。用于血虚萎黄，眩晕心悸，月经不调.经闭痛经.风湿痹痛，跌扑损伤。化学成分主要有挥发油部分和水溶性部分，挥发油部分包括中性、酸性以及酚性油3部分，其中，藁苯内酯是当归挥发油部分的主要成分，水溶性部分主要有阿魏酸及多糖等。具有保护心肌细胞、降低心肌耗氧量、扩张血管，降低血管阻力，改善器官血流量、抗肿瘤、抗菌、抗衰老、促进造血、美容等作用。
黄精：味甘、平，归脾、肺、肾经，具补肾益精、滋阴润燥之功，用于滋补强身和治疗肾虚精亏，肺虚燥咳以及脾胃虚弱之证。主要含有多糖、黄酮、生物碱、甾体皂苷、氨基酸、维生素以及多种矿物质等成分。具有降血糖、降血脂及抗动脉粥样硬化、延缓衰老、抗肿瘤、抗炎、抑菌、调节免疫力、改善学习记忆力、增强心肌收缩力、扩张冠脉、增加冠脉血流量、改善心机营养、抗缺氧性神经细胞坏死和凋亡、抗骨质疏松以及抗疲劳等作用。
茯苓：味甘、淡，性平。归经归心、肺、脾、肾经。利水渗湿，健脾，宁心。含有茯苓多糖及其衍生物、茯苓素、硬烷、麦角甾醇、纤维素、三萜类、月桂酸、十二酸、树胶、蛋白质、脂肪、酶、腺嘌呤、胆碱等成分。具有抗衰老、提高免疫力、抗肿瘤、利水消肿、预防结石、抗排斥反应、增白、抗迟发性超敏反应、抗菌、抗炎及抗病毒反应等。
本发明在具体实施的过程中也可以不改变现有原料的情况下增加其他药材，例如枸杞、山药、人参、鹿茸等。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内，不应将权利要求中的任何标记视为限制所涉及的权利要求。
此外，应当理解，虽然本说明书按照实施方式加以描述，但并非每个实施方式仅包含一个独立的技术方案，说明书的这种叙述方式仅仅是为清楚起见，本领域技术人员应当将说明书作为一个整体，各实施例中的技术方案也可以经适当组合，形成本领域技术人员可以理解的其他实施方式。
Claims (6)
1.一种具有保健功能的牛肉汤，其特征在于：原料包括食材和中药材，所述的食材包括牛骨和牛肉；所述的中药材包括当归，熟地，桂皮，生姜，铁皮石斛。
2.根据权利要求1所述的一种具有保健功能的牛肉汤，其特征在于：所述的原料配比为牛骨500g-800g，牛肉100g-250g，当归20g-30g，熟地30g-50g，桂皮40g-50g，生姜5g-10g，铁皮石斛10g-20g。
3.根据权利要求1所述的一种具有保健功能的牛肉汤，其特征在于：所述的牛骨健康牛骨。
4.根据权利要求1所述的一种具有保健功能的牛肉汤，其特征在于：所述的牛肉为除酸牛肉。
5.根据权利要求1所述的一种具有保健功能的牛肉汤，其制作方法是：
S1.选择优质的牛骨和牛肉，将牛骨和牛肉清洗干净后晾干；
S2.将晾干的牛骨粉碎成碎牛骨，并滤出比较细小的骨渣；
S3.将碎牛骨放在锅内小火煮20分钟后，将当归，熟地，桂皮，生姜，铁皮石斛放入锅内继续小火煮12小时；
S4.将牛肉切碎后放入锅内煮30分钟。
6.根据权利要求5所述的一种具有保健功能的牛肉汤，其特征在于：所述的步骤S2中对碎牛骨的过滤采用50目筛网。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710191365.0A CN106937733A (zh) | 2017-03-23 | 2017-03-23 | 一种具有保健功能的牛肉汤及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710191365.0A CN106937733A (zh) | 2017-03-23 | 2017-03-23 | 一种具有保健功能的牛肉汤及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106937733A true CN106937733A (zh) | 2017-07-11 |
Family
ID=59463102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710191365.0A Pending CN106937733A (zh) | 2017-03-23 | 2017-03-23 | 一种具有保健功能的牛肉汤及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106937733A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103637278A (zh) * | 2013-11-27 | 2014-03-19 | 许伟 | 一种健康养生牛肉汤 |
| CN104997080A (zh) * | 2015-06-24 | 2015-10-28 | 淮南市牛肉汤研究所 | 一种牛肉固态高汤及其制作工艺 |
| CN105167033A (zh) * | 2015-10-31 | 2015-12-23 | 齐艳华 | 一种秋季男生营养晚餐牛肉汤 |
| CN106174323A (zh) * | 2016-08-11 | 2016-12-07 | 董雪 | 一种路边菊和当归保健汤及其制备方法 |
-
2017
- 2017-03-23 CN CN201710191365.0A patent/CN106937733A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103637278A (zh) * | 2013-11-27 | 2014-03-19 | 许伟 | 一种健康养生牛肉汤 |
| CN104997080A (zh) * | 2015-06-24 | 2015-10-28 | 淮南市牛肉汤研究所 | 一种牛肉固态高汤及其制作工艺 |
| CN105167033A (zh) * | 2015-10-31 | 2015-12-23 | 齐艳华 | 一种秋季男生营养晚餐牛肉汤 |
| CN106174323A (zh) * | 2016-08-11 | 2016-12-07 | 董雪 | 一种路边菊和当归保健汤及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 台湾中药商业同业会著: "《五脏保养全书》", 31 May 2016, 青岛出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103478796A (zh) | 一种野生菌汤料的配方及生产方法 | |
| CN103266040B (zh) | 美容保健酒 | |
| CN104351790B (zh) | 保健食品 | |
| CN103859378A (zh) | 一种有助于降低血糖的养生保健食品配方及其制备方法 | |
| CN104288495A (zh) | 一种山药黄精胶囊及其制备方法 | |
| CN107772340A (zh) | 一种补肾滋阴壮阳黑色膳食纤维代餐食品 | |
| CN105211869A (zh) | 一种适用于秋季滋阴补津的营养食品 | |
| CN105432555A (zh) | 一种肉鸡饲养方法 | |
| CN106074973A (zh) | 一种提高免疫力的组合物及其制备方法 | |
| CN103484334A (zh) | 一种人参补脑健脑酒的配方及生产方法 | |
| CN105520069A (zh) | 一种卤水肘子 | |
| KR20090038595A (ko) | 보양식 순대소 조성물 및 그를 이용한 순대 제조방법 | |
| CN103468527A (zh) | 一种鹿茸健脑安神酒的配方及生产方法 | |
| CN1994397A (zh) | 海参紫丹胶囊 | |
| CN107874145A (zh) | 一种月子滋补鸡汤配方 | |
| CN104473179B (zh) | 治疗产后无乳的保健药膳及制备方法 | |
| CN107660715A (zh) | 一种中老年人滋补配方 | |
| CN106937733A (zh) | 一种具有保健功能的牛肉汤及其制备方法 | |
| CN104017701B (zh) | 一种五脏衡通养生保健酒 | |
| CN114748583A (zh) | 一种滋补养生的中药药酒 | |
| CN105851857A (zh) | 适用于中老年的面条及其加工方法 | |
| CN109480280A (zh) | 一种草本花果心脑舒全营养素及制备方法 | |
| CN104687137A (zh) | 一种鹿茸健脑安神汤料的配方及生产方法 | |
| CN109289017A (zh) | 用于清理血管和血液的组合物及制备方法 | |
| CN105876655A (zh) | 鸡肉豪猪夏季汤及其制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170711 |